Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion01:27

Glucose Homeostasis: Pancreatic Islets and Insulin Secretion

1.6K
The pancreatic islets comprising only 1%-2% of the volume are highly vascularized and innervated mini-organs. They contain five endocrine cell types, including β cells that secrete insulin, which is synthesized as a single polypeptide chain, preproinsulin, processed to proinsulin, and finally to insulin and C-peptide. This process is complex and regulated, involving the Golgi complex, the endoplasmic reticulum, and the secretory granules of the β cell.
Insulin and C-peptide are...
1.6K
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

358
Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
358
Insulin Secretory Vesicles01:05

Insulin Secretory Vesicles

6.1K
Insulin secretory vesicles release insulin to stimulate blood glucose uptake and regulate carbohydrate metabolism. When the blood glucose levels increase, glucose enters the pancreatic β-islet cells through glucose transporters. Once inside, glucose is metabolized through glycolysis, the citric acid cycle, and the electron transport chain, producing ATP. This increase in ATP concentration closes ATP-sensitive potassium channels, leading to depolarization of the membrane and the opening of...
6.1K
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

742
The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...
742
Glucagon-like Receptor Agonists01:24

Glucagon-like Receptor Agonists

516
Incretins include glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP), which stimulate insulin secretion post-meals. In type 2 diabetes, GIP's efficacy is reduced, making GLP-1 a viable drug target. GIP originates from preproGIP.
GLP-1, when administered in high doses intravenously, triggers insulin secretion, inhibits glucagon release, slows gastric emptying, reduces food intake, and restores normal insulin secretion. However, its rapid inactivation by...
516
Hormones Regulating Blood Glucose01:16

Hormones Regulating Blood Glucose

5.4K
Insulin is released by beta cells of the pancreas when blood glucose levels are high. It facilitates glucose absorption and utilization in insulin-dependent cells with insulin receptors on their plasma membranes. Insulin promotes glucose uptake by increasing the number of glucose transport proteins in the cell membrane, allowing glucose to enter the cell. As a result, glucose utilization and ATP production are enhanced.
In addition to accelerating glucose uptake and utilization, insulin has...
5.4K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tick-borne anaplasmosis and myocarditis in eastern Ontario.

CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne·2026
Same author

Genetic and Lifestyle Factors Influence High 1-Hour Plasma Glucose, a Predictor of Type 2 Diabetes Mellitus.

Diabetes & metabolism journal·2026
Same author

Defining disease or delaying care? A conceptual and clinical appraisal of the Lancet obesity framework.

The Journal of clinical endocrinology and metabolism·2026
Same author

Redefining β-Cell Function in Type 2 Diabetes Mellitus: From Comprehensive Assessment to Precision Medicine.

Diabetes & metabolism journal·2026
Same author

Is high insulin protective or detrimental? Mathematical modeling reveals the base of the iceberg.

American journal of physiology. Endocrinology and metabolism·2026
Same author

Being human: ableism, advocacy, and strengthening medicine.

Lancet (London, England)·2026

Related Experiment Video

Updated: Nov 6, 2025

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
07:30

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on: May 10, 2018

9.4K

When MINMOD Artifactually Interprets Strong Insulin Secretion as Weak Insulin Action.

Joon Ha1, Ranganath Muniyappa2, Arthur S Sherman1

  • 1Laboratory of Biological Modeling, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, United States.

Frontiers in Physiology
|May 10, 2021
PubMed
Summary

The Bergman-Cobelli Minimal Model may inaccurately estimate insulin sensitivity (Si) in certain simulated intravenous glucose tolerance tests (IVGTTs). This can lead to misinterpretations of racial differences in type 2 diabetes risk.

Keywords:
hyperinsulinemic euglycemic clampinsulin resistanceinsulin secretionminimal modelracial disparities

More Related Videos

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate
05:58

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate

Published on: June 25, 2019

7.7K
Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
08:22

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion

Published on: March 20, 2017

8.9K

Related Experiment Videos

Last Updated: Nov 6, 2025

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion
07:30

Homogeneous Time-resolved Förster Resonance Energy Transfer-based Assay for Detection of Insulin Secretion

Published on: May 10, 2018

9.4K
Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate
05:58

Measuring Relative Insulin Secretion using a Co-Secreted Luciferase Surrogate

Published on: June 25, 2019

7.7K
Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion
08:22

Combined Intravital Microscopy and Contrast-enhanced Ultrasonography of the Mouse Hindlimb to Study Insulin-induced Vasodilation and Muscle Perfusion

Published on: March 20, 2017

8.9K

Area of Science:

  • Metabolic research
  • Physiological modeling
  • Clinical diagnostics

Background:

  • The Bergman-Cobelli Minimal Model is widely used to estimate insulin sensitivity (Si) from intravenous glucose tolerance tests (IVGTTs).
  • Racial disparities in type 2 diabetes (T2D) risk are observed, with Black populations showing higher incidence.
  • Previous studies using the Minimal Model suggested lower Si in Black compared to White individuals, potentially explaining T2D risk differences.

Purpose of the Study:

  • To identify limitations of the Bergman-Cobelli Minimal Model in estimating insulin sensitivity (Si) during IVGTTs.
  • To investigate potential reasons for observed racial differences in Si estimates between Black and White populations.

Main Methods:

  • Simulated IVGTT data were analyzed to assess the Minimal Model's performance under specific physiological conditions.
  • Comparison of Minimal Model-derived Si estimates with established methods like the hyperinsulinemic euglycemic clamp (HIEC).

Main Results:

  • Simulated IVGTTs demonstrated that the Minimal Model can inaccurately estimate Si, particularly when high Acute Insulin Response (AIR) is present.
  • This inaccuracy may lead to the erroneous conclusion of lower Si in certain populations, such as Black individuals, even when actual insulin sensitivity is normal.
  • The rapid initial glucose rise and insulin dynamics in IVGTTs can be misinterpreted by the Minimal Model as reduced insulin sensitivity.

Conclusions:

  • Caution is advised when interpreting Minimal Model-derived Si estimates from IVGTTs, especially in diverse populations.
  • The model's limitations may contribute to perceived racial differences in insulin sensitivity, potentially misattributing T2D risk.
  • Further validation of the Minimal Model is needed, particularly concerning its application in studies comparing insulin sensitivity across different racial groups.